Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.28M Buy
81,862
+4,777
+6% +$474K 0.02% 466
2026
Q1
$7.26M Sell
77,085
-30,486
-28% -$3.04M 0.02% 485
2025
Q4
$10.6M Buy
107,571
+24,278
+29% +$2.35M 0.02% 434
2025
Q3
$7.06M Sell
83,293
-21,269
-20% -$1.68M 0.02% 485
2025
Q2
$7.12M Buy
104,562
+38,103
+57% +$2.41M 0.02% 481
2025
Q1
$4.02M Sell
66,459
-1,400
-2% -$97.6K 0.01% 571
2024
Q4
$4.69M Buy
67,859
+2,700
+4% +$192K 0.01% 544
2024
Q3
$4.31M Sell
65,159
-50,861
-44% -$3.24M 0.01% 567
2024
Q2
$7.03M Sell
116,020
-164,273
-59% -$9.3M 0.03% 446
2024
Q1
$16M Buy
+280,293
New +$16.8M 0.05% 330

Other funds holding INCY

Danske Bank's INCY Position: Q2 2026 in Review

Danske Bank increased its Incyte (INCY) stake by 6.2% in Q2 2026, buying an estimated $474K and bringing the position to 81,862 shares worth $9.28M. The position accounts for 0.02% of the portfolio, ranked #466.

Danske Bank first reported a position in INCY in Q1 2024 and has held it in 10 quarters since. The position peaked at $16M in Q1 2024. 860 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Danske Bank held 81,862 shares of Incyte worth $9.28M as of Q2 2026.
  • Danske Bank bought 4,777 Incyte shares in Q2 2026, an estimated $474K.
  • Incyte made up 0.02% of Danske Bank's portfolio in Q2 2026, its #466 holding.
  • Danske Bank first reported a position in Incyte in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Incyte position peaked at $16M in Q1 2024.
  • 860 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.